Real-time Estimate Tradegate 11:30:00 2024-04-25 am EDT 5-day change 1st Jan Change
40.18 EUR -3.19% Intraday chart for Stratec SE +2.12% -10.21%
Sales 2024 * 274M 293M Sales 2025 * 297M 317M Capitalization 504M 539M
Net income 2024 * 19M 20.31M Net income 2025 * 25M 26.73M EV / Sales 2024 * 2.25 x
Net Debt 2024 * 112M 120M Net Debt 2025 * 80.48M 86.04M EV / Sales 2025 * 1.97 x
P/E ratio 2024 *
25.3 x
P/E ratio 2025 *
19.5 x
Employees 1,480
Yield 2024 *
2.1%
Yield 2025 *
2.33%
Free-Float 59.43%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.69%
1 week+2.25%
Current month+1.87%
1 month-2.50%
3 months+0.61%
6 months+9.93%
Current year-10.10%
More quotes
1 week
39.00
Extreme 39
42.50
1 month
36.25
Extreme 36.25
42.95
Current year
36.25
Extreme 36.25
46.00
1 year
36.00
Extreme 36
69.00
3 years
36.00
Extreme 36
147.40
5 years
36.00
Extreme 36
147.40
10 years
32.10
Extreme 32.1
147.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 98-02-28
Director of Finance/CFO 56 98-04-30
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 57 19-05-28
Chairman 66 22-05-19
Director/Board Member 70 20-07-20
More insiders
Date Price Change Volume
24-04-25 40.9 -1.45% 27 569
24-04-24 41.5 +0.24% 16,531
24-04-23 41.4 +3.24% 6,321
24-04-22 40.1 -0.12% 3,839
24-04-19 40.15 +0.25% 5,382

Delayed Quote Xetra, April 25, 2024 at 08:40 am EDT

More quotes
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
41.5 EUR
Average target price
43.33 EUR
Spread / Average Target
+4.42%
Consensus

Quarterly revenue - Rate of surprise